Characterisation of 20-hydroxyvitamin D3 metabolism by human liver microsomal cytochromes P450

Chloe Cheng

Research output: Thesis › Doctoral Thesis

278 Downloads (Pure)

Abstract

20-Hydroxyvitamin D3 is a derivative of vitamin D3 that exhibits anti proliferative, prodifferentiative and immunomodulatory effects, thus showing promise as a therapeutic drug for the treatment of cancers and inflammatory diseases. To further characterise 20-hydroxyvitamin D3, its metabolism by human liver was investigated and it was found to be metabolised to three products, each with an additional hydroxyl group. The major cytochrome P450 enzyme responsible for these products was CYP3A4, with CYP2R1 playing a lesser role. These metabolic products, present in human serum, displayed stronger inhibition of melanoma cell proliferation than 20-hydroxyvitamin D3. Thus, liver P450s appear to activate 20-hydroxyvitamin D3.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Thesis sponsors
Award date17 Jun 2019
DOIs
Publication statusUnpublished - 2019

Access to Document

  • THESIS - DOCTOR OF PHILOSOPHY - CHENG YunnSan Chloe - 2019

    This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.

    Fingerprint Dive into the research topics of 'Characterisation of 20-hydroxyvitamin D3 metabolism by human liver microsomal cytochromes P450'. Together they form a unique fingerprint.

    Cite this